Navigation Links
Transdel Pharmaceuticals to Present at Rodman & Renshaw 10th Annual Global Healthcare Conference
Date:11/4/2008

LA JOLLA, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Dr. Juliet Singh, President and Chief Executive Officer of Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP, http://www.transdelpharma.com), will present at the Rodman & Renshaw Annual Global Healthcare Conference at the Palace Hotel in New York City. The Transdel presentation will be given in the Kennedy II room on the fourth floor of the hotel on Tuesday, November 11th at 2:25PM EST.

To listen to the audio web cast of the presentation, please visit the Investor Relations section of the Company's website at http://www.transdelpharma.com. An archive of the presentation will be available for replay for thirty days.

About Transdel Pharmaceuticals, Inc.

Transdel Pharmaceuticals, Inc. (OTCBB: TDLP) is a specialty pharmaceutical company developing non-invasive, topically delivered medications. The Company's innovative-patented proprietary Transdel(TM) cream formulation technology is designed to facilitate the effective penetration of drugs through the tough skin barrier to reach the target underlying tissues. In the case of Ketotransdel(TM), the Transdel(TM) cream allows the active ingredient ketoprofen to reach the target soft tissue and exert its well-known anti-inflammatory and analgesic effects. The Company is also investigating other drug candidates and treatments for transdermal delivery using the patented Transdel(TM) platform technology for products in pain management and other therapeutic areas. For more information, please visit http://www.transdelpharma.com.

Safe Harbor Statement

The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncer
'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Transdel Pharmaceuticals Closes $4 Million Financing
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
9. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
10. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
11. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment grew by ...only one to show consistent growth during the U.S....ls remain in trouble, and health systems are comin...el, instead of just administrators. , ...are employment continued growing in October despit...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- N...mp; Trademark Office (PTO) has allowed the patent ... NOD technology. , NOD technology is a hi...,proteins into bio-adhesive nano-particles to enab...s injections. NOD technology is a platform technol...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ --... & Drug Administration (SFDA) has approved the...s oral insulin project,(Nodlin), an innovative ins...val allows Biolaxy to initiate its first phase I c...haracteristic of high blood glucose and poor,metab...
(Date:11/24/2009)... The FBI recently approved the Pro...s participating in or generating DNA records for t... Madison, WI USA (PRWEB) -- The FBI recently... for use by laboratories participating in, or gen...stem (NDIS). NDIS currently contains more than sev...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...8% for Quarter, Increase 19.9% Year-to-Date - E...sus $(0.06) Year-to-D...etail Launch - Sees Substantial Increase in Sa...ant extension offer is successful, SAN DIEGO, Feb... today reported results for its third fiscal quart...
... 13 GeneGo, Inc., the leading,systems biology too...aborating with The Netherlands Toxicogenomics Cent...y program will use toxicogenomics to,develop highl...the in depth,evaluation of chemical safety for hum...experiments, and improving the scientific basis of...
... BioSpace, the world,s leading,online bioscience j...ted,over 1,000 biotechnology and pharmaceutical jo...lingame, CA on Monday February 4, 2008., The BioS...iotechnology,pharmaceutical, medical device, and d...ern California region. For admittance to the event...
Other Biology Technology:Imagenetix Inc. Reports Third Fiscal Quarter Results 2Imagenetix Inc. Reports Third Fiscal Quarter Results 3Imagenetix Inc. Reports Third Fiscal Quarter Results 4GeneGo Collaborates With The Netherlands Toxicogenomics Center on $100 Million Grant 2BioSpace Career Fair in San Francisco Welcomes Over 1,000 Bioscience Professionals 2
(Date:11/26/2009)...n eight European countries has shown that closing ...emic could have a significant role in reducing ill... access journal BMC Infectious Diseases compared...ekends/holidays, finding that they were reduced wh...nd Antwerp University, Belgium, led a team of Euro...
(Date:11/26/2009)...stant Staphylococcus Aureus ) and other drug-resi...erature plasma prototype devices have been develop...icidal cocktails. , Two prototype devices have b...ealthy skin (e.g. hands and feet) in hospitals and...reat; and another to shoot bacteria-killing agents...
(Date:11/25/2009)...don,t have easy lives. In addition to mammalian im...ral enemies called bacteriophages, viruses that ki... Still, bacteria and another class of microorganis...ironments such as deep-sea volcanic vents) manage ...built-in defense system that helps protect them fr...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 1National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 2National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 3National Coalition of Front Line Skilled Nursing Clinicians 3A Bipartisan Momentum to Stop CMS Medicare Regulation Subsequent Funding Cuts Grows in 53116 4Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies 13255 1Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies 13255 2Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies 13255 3Stryker Announces Election of New Director 53107 1Stryker Announces Election of New Director 53107 2
... demonstrated systemic spread of avian influenza v...nd cat-to-cat contact. The paper by Rimmelzwaan e... causes systemic disease with potential novel rout...ars in the January issue of The American Journal o..., Avian influenza (H5N1) is of great concern becau...
..., but it seems like everyone,s getting sick. What,...ectious invaders besides the flu to worry about. T...ock people down for days or weeks and cause thousa...noviruses. Coronaviruses. Parainfluenza. Respirato... the microbes can be almost as difficult as bearin...
...the wild more easily from a car than by foot may b...sual movements of an approaching predator,s feet, ..., "We believe this visual filter is used to signal... motion of their feet and the force of gravity," s... and Behavioural Sciences. , Conducted with Dr....
Other Biology News:Avian influenza virus in mammals spreads beyond the site of infection to other organ systems 2Flu not the only germ threat this time of year 2Flu not the only germ threat this time of year 3Flu not the only germ threat this time of year 4Animal brains 'hard-wired' to recognize predator's foot movements, Queen's study suggests 2
BD Falcon Center-well Organ Culture Dish, In Vitro Fertilization Dish from BD Biosciences - Discovery Labware
BD BioCoat Collagen I 60 mm Culture Dishes from BD Biosciences - Discovery Labware
BssH II Bacillus stearothermophilus from Sigma-Aldrich
Piston Kit, for F10 pump from Bio-Rad
Biology Products: